GLP-1 drugs: what New York Medicaid paid

Q: Does a paid prescription mean New York Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

New York Medicaid shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. A paid prescription records what happened and is not permission for what happens next, so read the figures below as a payment history rather than as a coverage rule.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What New York Medicaid’s payment record shows

In 2026Q1, the product New York Medicaid paid for most often was Ozempic®, at 112,157 prescriptions¹⁹ of the 196,755 to 196,863^{7,13,19,25,37,43} across all 8 products, or 57 percent of the published count.

New York Medicaid itself reimbursed at least $228,792,844 for these products in the quarter, about $1,163 per prescription. Pharmacies were paid $230,583,152 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Rybelsus®, at about $1,346.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what New York Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, New York Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What New York Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what New York Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	Withheld	n/a	Not published	Not published	Not published
tirzepatideMounjaro®	Both	at least 75,910⁷	39%	$82,659,364	$83,309,385	$1,089
semaglutideWegovy®	Fee-for-service	at least 1,945¹³	<1%	$2,176,158	$2,549,643	$1,119
semaglutideOzempic®	Both169 managed care, 111,988 direct	112,157¹⁹	57%	$135,578,929	$136,281,808	$1,209
semaglutideRybelsus®	Both12 managed care, 5,864 direct	at least 5,876²⁵	3%	$7,907,335	$7,970,861	$1,346
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	180³⁷	<1%	$152,730	$152,730	$849
liraglutideliraglutide (generic)	Fee-for-service	675⁴³	<1%	$318,327	$318,725	$472

New York Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 180 against 9,479. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 33.9 prescriptions per thousand people enrolled in New York Medicaid, on an average of 5,812,533 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 24 of the 168 product-quarters it holds a row for here, which is 14 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether New York Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what New York Medicaid paid for each product, quarter by quarter

Prescriptions New York Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter²No row	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable²Withheld2 of 2 product codes withheld	at least 11 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$1,041 paid	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable²Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable¹Withheld4 of 4 product codes withheld
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld2 of 2 product codes withheld	at least 198 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$186,549 paid	at least 812 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$749,991 paid	at least 1,876 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$1,799,239 paid	at least 7,834 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$7,832,278 paid	at least 13,100 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$13,008,452 paid	at least 17,478 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$17,405,134 paid	at least 20,999 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$21,855,374 paid	at least 23,628 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$24,891,894 paid	at least 32,247 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$33,899,021 paid	at least 35,634 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$37,379,118 paid	at least 42,051 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$44,332,014 paid	at least 50,110 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$53,119,838 paid	58,874 paid prescriptions in the quarter (2025Q3)⁸Count$62,600,972 paid	at least 67,829 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$72,291,597 paid	at least 75,910 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$82,659,364 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable¹⁷Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹⁷Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld4 of 4 product codes withheld	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable¹⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable¹⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable¹⁵Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable¹⁴Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable¹⁴Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable¹⁴Withheld2 of 2 product codes withheld	at least 197 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$214,617 paid	at least 1,945 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$2,176,158 paid
semaglutideOzempic®range 83,741 to 112,157	at least 20,013 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$16,679,544 paid	at least 24,387 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$20,487,879 paid	at least 27,830 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$23,467,179 paid	at least 31,836 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$26,776,797 paid	at least 35,639 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$30,978,091 paid	at least 42,183 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$36,750,756 paid	at least 48,423 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$42,218,513 paid	at least 53,349 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$46,561,798 paid	at least 63,827 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$57,859,252 paid	83,741 paid prescriptions in the quarter (2023Q2)²²Count$88,434,438 paid	at least 100,175 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$108,459,831 paid	at least 79,332 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$87,462,093 paid	at least 86,117 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$97,674,611 paid	at least 101,278 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$116,253,378 paid	at least 116,223 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$132,397,910 paid	at least 110,020 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$125,167,888 paid	at least 114,910 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$132,998,297 paid	at least 117,584 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$136,629,465 paid	at least 117,403 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$137,206,243 paid	at least 114,474 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$134,247,086 paid	112,157 paid prescriptions in the quarter (2026Q1)¹⁹Count$135,578,929 paid
semaglutideRybelsus®range 2,559 to 7,710	2,559 paid prescriptions in the quarter (2021Q1)³⁰Count$2,056,010 paid	3,977 paid prescriptions in the quarter (2021Q2)³⁰Count$3,215,894 paid	5,454 paid prescriptions in the quarter (2021Q3)³⁰Count$4,518,744 paid	at least 6,521 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$5,431,367 paid	7,710 paid prescriptions in the quarter (2022Q1)²⁹Count$6,678,017 paid	at least 9,009 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$7,857,851 paid	at least 10,128 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$8,849,257 paid	at least 11,210 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$9,864,990 paid	at least 12,583 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$11,779,189 paid	at least 9,939 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$11,143,514 paid	at least 8,662 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$10,261,020 paid	at least 7,911 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$9,768,735 paid	7,259 paid prescriptions in the quarter (2024Q1)²⁷Count$9,239,222 paid	7,253 paid prescriptions in the quarter (2024Q2)²⁷Count$9,361,239 paid	7,170 paid prescriptions in the quarter (2024Q3)²⁷Count$9,476,864 paid	6,251 paid prescriptions in the quarter (2024Q4)²⁷Count$8,311,681 paid	at least 6,105 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$8,199,679 paid	at least 6,126 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$8,320,961 paid	at least 6,121 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$8,197,329 paid	at least 5,900 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$7,898,870 paid	at least 5,876 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$7,907,335 paid
liraglutideSaxenda®	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 147 to 9,479, up 26 on the quarter before	9,479 paid prescriptions in the quarter (2021Q1)⁴²Count$8,390,994 paid	9,221 paid prescriptions in the quarter (2021Q2)⁴²Count$8,172,131 paid	8,092 paid prescriptions in the quarter (2021Q3)⁴²Count$7,187,681 paid	6,508 paid prescriptions in the quarter (2021Q4)⁴²Count$5,957,734 paid	5,837 paid prescriptions in the quarter (2022Q1)⁴¹Count$5,529,993 paid	5,490 paid prescriptions in the quarter (2022Q2)⁴¹Count$5,268,886 paid	5,259 paid prescriptions in the quarter (2022Q3)⁴¹Count$5,061,764 paid	4,825 paid prescriptions in the quarter (2022Q4)⁴¹Count$4,657,058 paid	4,695 paid prescriptions in the quarter (2023Q1)⁴⁰Count$4,682,705 paid	at least 4,185 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld⁴⁰At least$4,541,198 paid	at least 3,789 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld⁴⁰At least$4,329,694 paid	at least 2,947 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴⁰At least$3,423,223 paid	at least 2,389 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³⁹At least$2,213,275 paid	at least 1,969 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³⁹At least$1,640,214 paid	1,194 paid prescriptions in the quarter (2024Q3)³⁹Count$998,948 paid	at least 598 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$489,753 paid	351 paid prescriptions in the quarter (2025Q1)³⁸Count$263,365 paid	147 paid prescriptions in the quarter (2025Q2)³⁸Count$115,007 paid	164 paid prescriptions in the quarter (2025Q3)³⁸Count$130,412 paid	154 paid prescriptions in the quarter (2025Q4)³⁸Count$125,192 paid	180 paid prescriptions in the quarter (2026Q1)³⁷Count$152,730 paid
liraglutideliraglutide (generic)range 469 to 675	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	469 paid prescriptions in the quarter (2024Q3)⁴⁵Count$299,789 paid	at least 876 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$645,166 paid	at least 968 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$663,902 paid	at least 908 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$536,267 paid	at least 785 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$386,936 paid	at least 730 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$317,277 paid	675 paid prescriptions in the quarter (2026Q1)⁴³Count$318,327 paid

What New York Medicaid publishes as the rule

The figures above are payments. The rule that decides the next request is a different document, and where this site has read it the jurisdiction page carries it with the quote. Read the New York Medicaid coverage page.

Open New York in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, NY
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state NY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NY", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, NY
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state NY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, NY
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state NY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like ZEPBOUND%, state NY, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, NY
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state NY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like ZEPBOUND%, state NY, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, NY
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state NY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like ZEPBOUND%, state NY, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, NY
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state NY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like ZEPBOUND%, state NY, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, NY
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state NY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "19455"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, NY
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state NY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "17277"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, NY
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state NY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "10003"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, NY
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state NY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "5822"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, NY
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state NY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "306"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, NY
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state NY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like MOUNJARO%, state NY, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, NY
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state NY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "904"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, NY
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state NY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "129"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, NY
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state NY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, NY
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state NY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, NY
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state NY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, NY
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state NY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, NY
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state NY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "46080"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, NY
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state NY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "51743"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, NY
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state NY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "54120"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, NY
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state NY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2023", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "53132"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, NY
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state NY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "26349"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, NY
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state NY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "17228"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, NY
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state NY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "2414"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, NY
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state NY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "2445"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, NY
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state NY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "3115"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, NY
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state NY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "5299"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, NY
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state NY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "4802"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, NY
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state NY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2021", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "2590"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, NY
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state NY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like SAXENDA%, state NY, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, NY
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state NY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like SAXENDA%, state NY, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, NY
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state NY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like SAXENDA%, state NY, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, NY
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state NY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like SAXENDA%, state NY, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, NY
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state NY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, NY
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state NY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, NY
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state NY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "91"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, NY
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state NY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "183"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, NY
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state NY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "1551"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, NY
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state NY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "2546"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, NY
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state NY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "3112"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, NY
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state NY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "5456"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, NY
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state NY, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NY", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "207"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, NY
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state NY, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "504"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, NY
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state NY, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "566"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, NY
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state NY, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like LIRAGLUTID%, state NY, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, NY
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state NY, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like LIRAGLUTID%, state NY, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, NY
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state NY, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NY", "product_name": "product_name like LIRAGLUTID%, state NY, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 36 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 12 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean New York Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.